Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Epigenetics Market by Type
 5.1 Epigenetics Market Overview Snapshot and Growth Engine
 5.2 Epigenetics Market Overview
 5.3 Reagents
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2030F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Reagents: Geographic Segmentation
 5.4 Kits
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2030F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Kits: Geographic Segmentation
 5.5 Instruments
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2030F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Instruments: Geographic Segmentation
 5.6 Enzymes
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2030F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Enzymes: Geographic Segmentation
 5.7 Services
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2030F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Services: Geographic Segmentation

Chapter 6: Epigenetics Market by Application
 6.1 Epigenetics Market Overview Snapshot and Growth Engine
 6.2 Epigenetics Market Overview
 6.3 Oncology
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2030F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Oncology: Geographic Segmentation
 6.4 Non-Oncology
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2030F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Non-Oncology: Geographic Segmentation
 6.5 Solid Tumors
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2030F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Solid Tumors: Geographic Segmentation
 6.6 Liquid Tumors
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2030F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Liquid Tumors: Geographic Segmentation
 6.7 Inflammatory Diseases
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2016-2030F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Inflammatory Diseases: Geographic Segmentation
 6.8 Metabolic Diseases
  6.8.1 Introduction and Market Overview
  6.8.2 Historic and Forecasted Market Size (2016-2030F)
  6.8.3 Key Market Trends, Growth Factors and Opportunities
  6.8.4 Metabolic Diseases: Geographic Segmentation
 6.9 Infectious Diseases
  6.9.1 Introduction and Market Overview
  6.9.2 Historic and Forecasted Market Size (2016-2030F)
  6.9.3 Key Market Trends, Growth Factors and Opportunities
  6.9.4 Infectious Diseases: Geographic Segmentation
 6.10 Cardiovascular Diseases
  6.10.1 Introduction and Market Overview
  6.10.2 Historic and Forecasted Market Size (2016-2030F)
  6.10.3 Key Market Trends, Growth Factors and Opportunities
  6.10.4 Cardiovascular Diseases: Geographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Epigenetics Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Epigenetics Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Epigenetics Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 ROCHE
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 ILLUMINA INC
 7.4 NOVARTIS AG
 7.5 MERCK & CO. LTD.
 7.6 VALIRX PLC
 7.7 CELLCENTRIC LIMITED
 7.8 QIAGEN
 7.9 ABCAM
 7.10 EISAI CO. LTD.
 7.11 CHROMA THERAPEUTICS
 7.12 THERMO FISHER SCIENTIFIC
 7.13 ZYMO RESEARCH CORPORATION
 7.14 SIGMA-ALDRICH CORPORATION
 7.15 SYNDEX PHARMACEUTICALS
 7.16 DIAGENODE
 7.17 ONCOLOYS BIOPHARMA INC.
 7.18 ACTIVE MOTIF INC.

Chapter 8: Global Epigenetics Market Analysis, Insights and Forecast, 2016-2030
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Type
  8.2.1 Reagents
  8.2.2 Kits
  8.2.3 Instruments
  8.2.4 Enzymes
  8.2.5 Services
 8.3 Historic and Forecasted Market Size By Application
  8.3.1 Oncology
  8.3.2 Non-Oncology
  8.3.3 Solid Tumors
  8.3.4 Liquid Tumors
  8.3.5 Inflammatory Diseases
  8.3.6 Metabolic Diseases
  8.3.7 Infectious Diseases
  8.3.8 Cardiovascular Diseases

Chapter 9: North America Epigenetics Market Analysis, Insights and Forecast, 2016-2030
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Reagents
  9.4.2 Kits
  9.4.3 Instruments
  9.4.4 Enzymes
  9.4.5 Services
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Oncology
  9.5.2 Non-Oncology
  9.5.3 Solid Tumors
  9.5.4 Liquid Tumors
  9.5.5 Inflammatory Diseases
  9.5.6 Metabolic Diseases
  9.5.7 Infectious Diseases
  9.5.8 Cardiovascular Diseases
 9.6 Historic and Forecast Market Size by Country
  9.6.1 US
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Eastern Europe Epigenetics Market Analysis, Insights and Forecast, 2016-2030
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Reagents
  10.4.2 Kits
  10.4.3 Instruments
  10.4.4 Enzymes
  10.4.5 Services
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Oncology
  10.5.2 Non-Oncology
  10.5.3 Solid Tumors
  10.5.4 Liquid Tumors
  10.5.5 Inflammatory Diseases
  10.5.6 Metabolic Diseases
  10.5.7 Infectious Diseases
  10.5.8 Cardiovascular Diseases
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Bulgaria
  10.6.2 The Czech Republic
  10.6.3 Hungary
  10.6.4 Poland
  10.6.5 Romania
  10.6.6 Rest of Eastern Europe

Chapter 11: Western Europe Epigenetics Market Analysis, Insights and Forecast, 2016-2030
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Reagents
  11.4.2 Kits
  11.4.3 Instruments
  11.4.4 Enzymes
  11.4.5 Services
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Oncology
  11.5.2 Non-Oncology
  11.5.3 Solid Tumors
  11.5.4 Liquid Tumors
  11.5.5 Inflammatory Diseases
  11.5.6 Metabolic Diseases
  11.5.7 Infectious Diseases
  11.5.8 Cardiovascular Diseases
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Germany
  11.6.2 UK
  11.6.3 France
  11.6.4 Netherlands
  11.6.5 Italy
  11.6.6 Russia
  11.6.7 Spain
  11.6.8 Rest of Western Europe

Chapter 12: Asia Pacific Epigenetics Market Analysis, Insights and Forecast, 2016-2030
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Reagents
  12.4.2 Kits
  12.4.3 Instruments
  12.4.4 Enzymes
  12.4.5 Services
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Oncology
  12.5.2 Non-Oncology
  12.5.3 Solid Tumors
  12.5.4 Liquid Tumors
  12.5.5 Inflammatory Diseases
  12.5.6 Metabolic Diseases
  12.5.7 Infectious Diseases
  12.5.8 Cardiovascular Diseases
 12.6 Historic and Forecast Market Size by Country
  12.6.1 China
  12.6.2 India
  12.6.3 Japan
  12.6.4 South Korea
  12.6.5 Malaysia
  12.6.6 Thailand
  12.6.7 Vietnam
  12.6.8 The Philippines
  12.6.9 Australia
  12.6.10 New Zealand
  12.6.11 Rest of APAC

Chapter 13: Middle East & Africa Epigenetics Market Analysis, Insights and Forecast, 2016-2030
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Reagents
  13.4.2 Kits
  13.4.3 Instruments
  13.4.4 Enzymes
  13.4.5 Services
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Oncology
  13.5.2 Non-Oncology
  13.5.3 Solid Tumors
  13.5.4 Liquid Tumors
  13.5.5 Inflammatory Diseases
  13.5.6 Metabolic Diseases
  13.5.7 Infectious Diseases
  13.5.8 Cardiovascular Diseases
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Turkey
  13.6.2 Bahrain
  13.6.3 Kuwait
  13.6.4 Saudi Arabia
  13.6.5 Qatar
  13.6.6 UAE
  13.6.7 Israel
  13.6.8 South Africa

Chapter 14: South America Epigenetics Market Analysis, Insights and Forecast, 2016-2030
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Reagents
  14.4.2 Kits
  14.4.3 Instruments
  14.4.4 Enzymes
  14.4.5 Services
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Oncology
  14.5.2 Non-Oncology
  14.5.3 Solid Tumors
  14.5.4 Liquid Tumors
  14.5.5 Inflammatory Diseases
  14.5.6 Metabolic Diseases
  14.5.7 Infectious Diseases
  14.5.8 Cardiovascular Diseases
 14.6 Historic and Forecast Market Size by Country
  14.6.1 Brazil
  14.6.2 Argentina
  14.6.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

Epigenetics Scope:

Report Data	Epigenetics Market
Epigenetics Market Size in 2022	USD XXX million
Epigenetics CAGR 2023 - 2030	XX%
Epigenetics Base Year	2022
Epigenetics Forecast Data	2023 - 2030
Segments Covered	By Type, By Application, And by Regions
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	Roche, Illumina Inc, Novartis AG, Merck & Co. Ltd., Valirx Plc, Cellcentric Limited, Qiagen, Abcam, Eisai Co. Ltd., Chroma Therapeutics, Thermo Fisher Scientific, Zymo Research Corporation, Sigma-Aldrich Corporation, Syndex Pharmaceuticals, Diagenode, Oncoloys Biopharma Inc., Active Motif Inc..
Key Segments	By Type Reagents Kits Instruments Enzymes Services By Applications Oncology Non-Oncology Solid Tumors Liquid Tumors Inflammatory Diseases Metabolic Diseases Infectious Diseases Cardiovascular Diseases

 

Research Methodology